| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.45B | 13.07B | 11.82B | 10.82B | 9.58B | 8.32B |
| Gross Profit | 2.24B | 2.14B | 1.74B | 1.35B | 1.13B | 314.63M |
| EBITDA | 1.49B | 1.44B | 1.26B | 879.51M | 328.91M | -848.27M |
| Net Income | 353.69M | 421.88M | 353.26M | -506.11M | 93.29M | 150.73M |
Balance Sheet | ||||||
| Total Assets | 11.64B | 12.47B | 11.66B | 11.74B | 12.07B | 10.50B |
| Cash, Cash Equivalents and Short-Term Investments | 2.39B | 2.35B | 1.67B | 1.31B | 948.20M | 825.00M |
| Total Debt | 6.34B | 7.16B | 7.86B | 8.68B | 8.64B | 7.25B |
| Total Liabilities | 8.53B | 9.65B | 9.91B | 10.40B | 10.48B | 9.07B |
| Stockholders Equity | 3.11B | 2.82B | 1.75B | 1.34B | 1.59B | 1.43B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.05B | 1.19B | 88.11M | -1.12B | -1.74B |
| Operating Cash Flow | 0.00 | 1.39B | 1.77B | 873.87M | 595.53M | 385.68M |
| Investing Cash Flow | 0.00 | -424.26M | -619.00M | -809.07M | -1.71B | -2.90B |
| Financing Cash Flow | 0.00 | -291.08M | -786.22M | 293.35M | 1.25B | 2.19B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥2.98B | 27.02 | ― | 2.56% | -3.06% | -38.56% | |
72 Outperform | ¥42.91B | 11.61 | ― | 2.63% | 0.30% | -31.28% | |
65 Neutral | ¥8.18B | 12.59 | ― | ― | 14.05% | -12.70% | |
60 Neutral | ¥5.75B | 23.20 | ― | 4.07% | 6.08% | 38.00% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
45 Neutral | ¥6.54B | 33.86 | ― | 1.41% | 18.03% | -11.68% |